During the 40th Annual J.P. Morgan Healthcare Conference on Monday, Pfizer CEO Albert Bourla said that two doses of the Pfizer/BioNTech COVID-19 vaccine are “not enough” for protection against the new Omicron variant. “Omicron is a way more challenging target, so the two doses are not enough for Omicron,” Bourla said. “The third dose of
More
As the new Omicron variant leads to record high cases of COVID-19, the Food and Drug Administration (FDA) has approved COVID-19 boosters for children between the ages of 12 and 15 for
Federal health officials are reportedly considering changing the definition of “fully vaccinated” to only individuals who have received a booster shot in addition to their original COVID-19 vaccination. According to the New
As Israel’s government is deciding whether to approve a fourth dose of COVID-19 vaccines, experts have warned that an additional dose is not backed by data and could actually be detrimental to
The efficacy of COVID-19 vaccine booster shots against symptomatic cases of the Omicron variant wanes significantly after 10 weeks, according to new data from the UK. In the report, the UK Health Security
